Zheng and colleagues used public data sets to analyze t the expression of TLRs and downstream adaptor proteins in COVID-19 patients with varying degrees of disease progression revealed that E protein can activate TLR2 and downstream immune signaling pathways. Here, TLR2 is linked to COVID-19.